Abstract
A 72-year-old male with atrial fibrillation was transferred to our clinic for the evaluation of the interventional closure of the left atrial appendage (LAA) after a major bleeding complication under the novel anti-factor Xa inhibitor rivaroxaban. He had a history of biological aortic valve (AV) replacement and pericardial patch plastic of the left ventricular outflow tract (LVOT) after abscess forming infective endocarditis of the AV and LVOT ( Panel A , preoperative state, arrows …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
